alegro health semaglutide & Wellness At Alegro Health, we believe

Some people notice changes within hours, while others see the full effect build over several weekly sessions

The STEP 5 trial assessed the efficacy and safety of once-weekly subcutaneous Semaglutide 2.4 mg versus placebo (both plus behavioral modification)

It addresses functional B-vitamin insufficiency, particularly during periods of stress or increased metabolic demand, while avoiding imbalance that can occur when single B vitamins are given in isolation

While it can be highly effective for the right patient, appropriate use depends on a careful assessment of an individuals medical history, metabolic profile, and long-term weight loss goals

All histological sections were blindly evaluated by the same investigator